Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Dividends Paid - Common (2017 - 2025)

Fortress Biotech has reported Dividends Paid - Common over the past 9 years, most recently at -$498000.0 for Q4 2025.

  • Quarterly results put Dividends Paid - Common at -$498000.0 for Q4 2025, up 85.01% from a year ago — trailing twelve months through Sep 2025 was -$2.8 million (down 122.01% YoY), and the annual figure for FY2024 was $694000.0, down 5.71%.
  • Dividends Paid - Common for Q4 2025 was -$498000.0 at Fortress Biotech, down from $166000.0 in the prior quarter.
  • Over the last five years, Dividends Paid - Common for FBIO hit a ceiling of $3.7 million in Q3 2024 and a floor of -$5.3 million in Q4 2023.
  • Median Dividends Paid - Common over the past 5 years was $187000.0 (2021), compared with a mean of -$37842.1.
  • Biggest five-year swings in Dividends Paid - Common: tumbled 2943.01% in 2023 and later soared 1880.54% in 2024.
  • Fortress Biotech's Dividends Paid - Common stood at $187000.0 in 2021, then decreased by 0.53% to $186000.0 in 2022, then tumbled by 2943.01% to -$5.3 million in 2023, then surged by 37.18% to -$3.3 million in 2024, then soared by 85.01% to -$498000.0 in 2025.
  • The last three reported values for Dividends Paid - Common were -$498000.0 (Q4 2025), $166000.0 (Q3 2025), and $332000.0 (Q2 2025) per Business Quant data.